AX
AXIM Biotechnologies, Inc.
AXIM · OTC
$0.00 -7.51% (-$0.00)
1M -16.09%
Market Cap $1.33M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0
100.0% downside
Current Price
$0.0036
Undervalued Fair Value Overvalued
According to Bulios Fair Price, AXIM is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
86 /100
Cheap P/S 3.39x
P/FCF 1.88x
P/E N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
30 /100
Weak Gross margin 8.71%
Net margin 208.79%
Op. margin 268.08%
Quality
59 /100
Average ROIC 36.82%
ROA 24.88%
Asset turnover 0.12x
Debt
0 /100
High Current ratio 0.00x
Int. coverage -2.83x
Debt/Equity N/A
Stability
29 /100
Unstable Beta -0.11x
Rev. volatility 224.10%
EPS volatility 39.69%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AXIM
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Catalina Valencia
Employees
7
Headquarters
San Diego